NASDAQ:DFNS

Nukkleus Q4 2023 Earnings Report

Nukkleus logo
$0.17 -0.01 (-5.45%)
As of 09:51 AM Eastern

Nukkleus EPS Results

Actual EPS
-$1.36
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nukkleus Revenue Results

Actual Revenue
$0.26 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nukkleus Announcement Details

Quarter
Q4 2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Nukkleus Earnings Headlines

Trump’s Currency Coup Exposed
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel
See More Nukkleus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nukkleus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nukkleus and other key companies, straight to your email.

About Nukkleus

Nukkleus (NASDAQ:DFNS), a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey.

View Nukkleus Profile